Skip to main content
Heliyon logoLink to Heliyon
. 2021 Sep 6;7(9):e07936. doi: 10.1016/j.heliyon.2021.e07936

Detection of SARS-CoV-2 spike protein D614G mutation by qPCR-HRM analysis

Faris Muhammad Gazali a, Matin Nuhamunada b, Rahma Nabilla c, Endah Supriyati d, Mohamad Saifudin Hakim e, Eggi Arguni f, Edwin Widyanto Daniwijaya e, Titik Nuryastuti e, Sofia Mubarika Haryana g, Tri Wibawa e, Nastiti Wijayanti h,
PMCID: PMC8420086  PMID: 34514180

Abstract

Objectives

Monitoring the spread of the G614 in specific locations is critical as this variant is highly transmissible and can trigger the emergence of other mutations. Therefore, a rapid and accurate method that can reliably detect the D614G mutation will be beneficial. This study aims to analyze the potential use of the two-step Reverse Transcriptase quantitative polymerase chain reaction - high resolution melting analysis (RT-qPCR-HRM) to detect a specific mutation in the SARS-CoV-2 genome.

Methods

Six SARS-CoV-2 RNA samples were synthesized into cDNA and analyzed with the qPCR-HRM method in order to detect the D614G mutation in Spike protein of SARS-CoV-2. The primers are designed to target the specific Spike region containing the D614G mutation. The qPCR-HRM analysis was conducted simultaneously, and the identification of the SARS-CoV-2 variant was confirmed by conventional PCR and Sanger sequencing methods.

Results

The results showed that the melting temperature (Tm) of the D614 variant was 79.39 ± 0.03 °C, which was slightly lower than the Tm of the G614 variant (79.62 ± 0.015 °C). The results of the HRM analysis, visualized by the normalized melting curve and the difference curve were able to discriminate the D614 and G614 variant samples. All samples were identified as G614 variants by qPCR-HRM assay, which was subsequently confirmed by Sanger sequencing.

Conclusions

This study demonstrated a sensitive method that can identify the D614G mutation by a simple two-step RT-qPCR-HRM assay procedure analysis, which can be useful for active surveillance of the transmission of a specific mutation.

Keywords: SARS-CoV-2, D614G, Spike, qPCR, HRM analysis


SARS-CoV-2; D614G; Spike; qPCR; HRM analysis

1. Introduction

Since it first appeared in Wuhan in late December 2019, the severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2), the cause of Coronavirus Disease 2019 (COVID-19), has spread worldwide and becomes the current major healthcare problem [1, 2, 3, 4, 5]. The viral mutation has occurred frequently since the first outbreak and has increased rapidly with increasing transmission [6]. One of the important mutations in the SARS-CoV-2 genome is the missense located in the Spike (S) protein, which led to the replacement of amino acid from Aspartic Acid (D) to Glutamic Acid (G), at residue 614 [6, 7]. This mutation is known as the D614G, which has been shown to affect the infectivity of SARS-CoV-2 in vitro and in vivo [8, 9, 10]. The G614 variant had higher infectivity and could become the dominant circulating variant and replace the original D614 variant [6, 9, 11]. An effective mutation surveillance study should be considered because of its high infectivity property, which causes a greater probability to reach out to the higher risk community [3]. This approach can be efficient in supporting rapid and cost-effective detection methods, instead of relying on the high-cost and time-consuming sequencing-based detection method [12].

Several approaches have been developed to rapidly detect the D614G mutation. Furthermore, it was shown that the engineered Cas12 guide RNA reliably differentiates between variant D614 and G614 [13]. The RT-qPCR assay was also specially developed to perform a D614G genotyping that could distinguish the two variants [14]. Another study illustrated that the Biosensing approach was also reliable in detecting the D614G mutation [15]. The PCR-RFLP method has also been described to detect the D614G mutation, but the data were ultimately misinterpreted [16, 17]. Another possible and reliable method for detecting SNP is real-time PCR and high-resolution melting curve analysis (HRM) [12]. In addition, it has been reported that the HRM analysis accurately distinguishes between GR and non-GR clades of SARS-CoV-2 [18].

The HRM analysis is widely used for many purposes, particularly for detecting mutations [19]. This approach is a post-PCR protocol and is considered a powerful method for SNP detection [12]. This can be performed by determining the differences in the melting temperature between the samples, whereby a single change in the base can affect the melting temperature of the PCR product [20]. This technique has made it possible to distinguish SNPs with high accuracy and low cost, which are widely used in many areas, such as human genetic screening for specific disease susceptibilities, genotyping of drug resistance, as well as intra-microbial species genotyping [12, 19, 21, 22, 23, 24, 25]. This suggests that SNP genotyping by RT-qPCR-HRM analysis can detect the D614G mutation in SARS-CoV-2.

This study developed a sensitive method for the detection of the D614G mutation of SARS-CoV-2. The differences between the D614 and G614 variants of SARS-CoV-2 were distinguish using the two-step RT-qPCR-HRM analysis method. Furthermore, this is the first study that describes the reliability of the qPCR-HRM assay for the detection of D614G mutations in SARS-CoV-2 and provides a model that can be developed for the detection of other mutations in SARS-CoV-2.

2. Methods

2.1. Sample collection and primer design

Six RNA samples from specimens confirmed positive for SARS-CoV-2 were used. These samples are part of the sample collection from the COVID-19 Diagnostic Laboratory, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, Indonesia. Furthermore, two samples were used as reference strains, one of which was identified as variant D614 (Sample ID: 3.09) and the other as variant G614 (Sample ID: 3.13). Four samples with unknown variance were used as research samples (Sample ID: 2.14, 3.08, 3.17, and 3.24). The research protocol has been approved by the Medical and Health Research Ethics Committee (MHREC), Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, Indonesia (EC: KE/FK/0511/EC/2020).

A primer pair was designed to target the specific region containing the D614G mutation (Table 1). Furthermore, the primers amplified the target region from nucleotide position 23.286 to 23.434 of the Wuhan-Hu-1 reference sequence (NC_045512.2). The primers were used for qPCR-HRM assay as well as for PCR and sequencing procedures.

Table 1.

The primers for qPCR-HRM assay.

Primer Name Type Primer Sequence Primer Length Primer GC Content (%) Amplicon Size (bp)
F3.CoV-2-S Forward CTG TCC GTG ATC CAC AGA CAC T 22 55 172
R8.CoV-2-S Reverse GTA GGA GTA AGT TGA TCT GCA TG 23 42

2.2. cDNA synthesis

The RNA was converted to the first strand of cDNA using the Reverse Transcription Kit II (ExcelRT™ series, Smobio), according to the manufacturer's instructions. The RNA was incubated with the primer mixture (50 μM oligo (dT)20 and 100 μM random hexamers) in a total volume of 10 μl at 70 °C for 5 min, followed by incubation in ice for at least 1 min. The first reaction volume of cDNA synthesis of 20 μl was completed by adding 5x RT Buffer, RTase, and DEPC-treated water, followed by a subsequent incubation at 20, 50, and 85 °C for 10, 60, and 5 min, respectively.

2.3. qPCR and HRM

qPCR was performed using THUNDERBIRDTM SYBRTM qPCR Mix (Toyobo), according to the manufacturer's instructions. The cDNA concentration was equalized to 100 ng/μl. A total of 20 μl qPCR reactions, each containing 0.2 μM forward and reverse primer, cDNA template, qPCR mix, and nuclease-free water, were incubated according to the qPCR amplification steps: 95 °C 1 min; 45 cycles of 95 °C 5 s and 60 °C 30 s.

The qPCR product was used for post-PCR analysis with HRM. The qPCR product was incubated at 95 °C for 1 min and 60 °C for 1 min, followed by melting curve steps from 65 to 95 °C with the increment temperature 0.1 °C/s. The melting curve-RFU data from 78.3 to 81.5 °C were analyzed using the PyHRM code of Python (ver. 3.8.3) in order to generate the normalized melting curve and the difference curve of the HRM profile [26].

2.4. PCR and sequencing

PCR was performed using Gotaq ® Green Mastermix (Promega). A total of 25 μl PCR reactions, comprising 0.2 μM of each forward and reverse primer, cDNA template, PCR mix, and nuclease-free water, was incubated following the PCR amplification steps: 95 °C 3 min; 35 cycles of 95 °C 30 s, 60 °C 45 s, and 72 °C 45 s; and final extension 72 °C 2 min.

The amplicon was sequenced using the Sanger method. All sequencing procedures using BigDye® Terminator v3.1 cycle sequencing kit chemistry (Applied Biosystems) were performed by DNA Sequencing Services (Genetika Science, Indonesia; 1st Base, Singapore).

3. Results

3.1. qPCR-HRM analysis of the D614 and G614 variant specimens

The preliminary HRM analysis of the two control specimens identified as the D614 variant (Sample ID: 3.09) and the G614 variant was performed (Sample ID: 3.13) in triplicate, resulting in a different melting temperature between the two groups (Table 2). Furthermore, the G614 variant showed a slightly higher melting temperature (79.62 °C) compared to the D614 variant (79.39 °C). Low standard deviation values (0.015–0.03) between the two variants allowed differentiation in a high-resolution difference, as shown in the normalized melting and difference curve of HRM profile (Figure 1).

Table 2.

The melting temperature (Tm) of D614 and G614 variant amplicon.

SARS-CoV-2 Variant Sample ID Tm (°C)
Mean SD
D614 3.09 79.39 0.03
G614 3.13 79.62 0.015

Figure 1.

Figure 1

HRM profiles of D614 variant (Sample ID: 3.09) and G614 variant (Sample ID: 3.13). HRM profiles showed that D614 and G614 variants clustered distinctively, both by the visualization of the normalized melting curve (a) and difference curve (b).

3.2. qPCR-HRM analysis of unidentified-variant specimens

A total of two specimens from Central Java (Sample ID: 3.24 and 3.17) and two from Yogyakarta (Sample ID: 2.14 and 3.08), collected from June to September 2020, were analyzed by the same protocol as described in the previous section. Furthermore, specimens 3.09 and 3.13 were used as reference strains of the D614 and G614 variants, respectively. The HRM analysis showed that all four unidentified-variant specimens were identified as G614 variants, as they clustered with the G614 variant reference strain (Sample ID: 3.13) (Figure 2).

Figure 2.

Figure 2

HRM profiles of unidentified-variant samples. HRM profiles showed that all four unidentified-variant samples (Sample ID: 2.14, 3.08, 3.17, 3.24) were identified as the G614 variant, as they clustered together with our G614 variant reference strain (Sample ID: 3.13), clearly indicated in both the normalized melting curve (a) and the difference curve (b).

3.3. Sequence read of HRM-Analyzed samples

All four samples that have been detected as the G614 variant by HRM analysis were sequenced using the Sanger Method. The sequencing results showed and confirmed the HRM analysis that all samples were identified as G614 variant by the presence of missense mutation A to G at position 23403 (NCBI Reference Sequence Wuhan-Hu-1/NC_045512.2 = 23403A > G) which causes changes in the amino acid, Aspartic Acid (D) into Glycine (G) at the Spike residue 614 (D614G) (Figure 3).

Figure 3.

Figure 3

Sequence reads of HRM-analyzed samples. All four unidentified-variant specimens (Sample ID: 2.14, 3.08, 3.17, 3.24) which have been identified as the G614 variant by the qPCR-HRM analysis were confirmed as the G614 variant by Sanger sequencing.

4. Discussion

This study described the qPCR-HRM analysis method as a sensitive method that can reliably detect D614G mutation in the S gene of SARS-CoV-2. A primer pair was designed (F3.CoV-2.S and R8.CoV-2.S), which amplified 172 bp-length regions containing the hotspot mutation of D614G within the S gene. Furthermore, HRM analysis of reference samples, the D614 variant (Sample ID = 3.09) and the G614 variant (Sample ID = 3.13) showed different melting temperatures (Tm). The G614 variant was slightly higher (79.62 ± 0.015 °C) than the D614 variant (79.39 ± 0.03 °C) (Table 2). The G614 variant carried the missense mutation 23403A > G (Reference Sequence = NC_04512.2), which allowed the higher melting temperature, as Guanine (G) base needs 3 hydrogen bonds to form a base pair, whereas Adenine (A) base needs only 2 hydrogen bonds [27]. This created two distinct plots, which can differentiate the D614 and G614 variants in a high-resolution normalized melting and difference curve (Figure 1).

To validate this method, four additional samples were examined by qPCR-HRM analysis after cDNA synthesis. All samples were identified as G614 variants (Figure 2) as they were all clustered with the G614 variant reference sample and this was confirmed by the sequencing results (Figure 3). Furthermore, the qPCR-HRM method was proposed and is capable of detecting the D614G mutation by reliably distinguishing the D614 and G614 variants. A similar study examining the main clades of SARS-CoV-2 also proved that HRM analysis can effectively differentiate between variants of SARS-CoV-2 [18]. The other study described that HRM analysis also can rapidly differentiate Influenza A virus subtypes [28]. Therefore, this study suggests that a qPCR-HRM method is a powerful tool for high-throughput screening and epidemiological study of circulating SARS-CoV-2 variants in a specific location, as this technique is fast, efficient, and cost-effective, compared with the time-consuming and high-cost sequencing-based method.

Surveillance for the D614G mutation is important because the variant that contains this mutation, or the G614 variant, is more transmissible and has become the dominant variant of SARS-CoV-2 that has been circulated around the world, including Indonesia [5, 6]. Compare with other countries like Costa Rika, which was dominated by the G614 variant by 98.9%, the prevalence of the G614 variant detected in Indonesia was only 65% in September 2020 [5, 29]. In addition, all variants of concerns (VOCs) of SARS-CoV-2, which are considered to be more transmissible, pathogenic, and immune-resistant, were generated from the G614 variant lineage [30, 31, 32, 33]. Therefore, the qPCR-HRM method might help to rapidly and efficiently monitor the spread of this G614 variant in a specific area. For further study, this qPCR-HRM method can be improved by designing primers for specific mutations of certain SARS-CoV-2 variants, including the VOCs, thereby highlighting the importance of the qPCR-HRM method for SARS-CoV-2 variants surveillance.

However, this qPCR-HRM assay has several limitations. Any further mutation in the target area can affect the melting temperature and lead to misinterpretations. Surveillance of the mutations by DNA sequencing should be performed regularly to determine whether there are other mutations besides D614G, which might affect the HRM results. The development of the one-step RT-qPCR method for HRM analysis can improve efficiency and time, as well as reduce the risk of cross-contamination.

In conclusion, this study suggests that the D614G mutation of SARS-CoV-2 Spike protein can be detected by the qPCR-HRM assay, which will help to rapidly trace the circulating SARS-CoV-2 variants in certain locations.

Declarations

Author contribution statement

Faris Muhammad Gazali: Conceived and designed the experiments; Performed the experiments; Analyzed and interpreted the data; Wrote the paper.

Matin Nuhamunada: Conceived and designed the experiments; Wrote the paper.

Rahma Nabilla: Performed the experiments; Analyzed and interpreted the data.

Endah Supriyati, Edwin Widyanto Daniwijaya: Performed the experiments; Wrote the paper.

Mohamad Saifudin Hakim, Eggi Arguni, Titik Nuryastuti, Sofia Mubarika Haryana: Conceived and designed the experiments; Wrote the paper.

Tri Wibawa: Conceived and designed the experiments; Analyzed and interpreted the data; Wrote the paper.

Nastiti Wijayanti: Conceived and designed the experiments; Performed the experiments; Analyzed and interpreted the data; Wrote the paper.

Funding statement

This work was partly supported by the COVID-19 Research Grant from the Universitas Gadjah Mada (to S. M. H).

Data availability statement

The data will be published in the GISAID and/or NCBI after the manuscript is published.

Declaration of interests statement

The authors declare no conflict of interest.

Additional information

No additional information is available for this paper.

Acknowledgements

The authors would like to acknowledge all the laboratory staffs at COVID-19 diagnostic laboratory, Universitas Gadjah Mada, for providing the SARS-CoV-2 RNA specimens. We thank Arsiyah and Chahyaning Ardhiani from the Research Center for Biotechnology Universitas Gadjah Mada for the laboratory technical assistance.

References

  • 1.Andersen K.G., Rambaut A., Lipkin W.I., Holmes E.C., Garry R.F. The proximal origin of SARS-CoV-2. Nat. Med. 2020;26:450–452. doi: 10.1038/s41591-020-0820-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Zhou P., Yang X.-L., Wang X.-G., Hu B., Zhang L., Zhang W., Si H.-R., Zhu Y., Li B., Huang C.-L., Chen H.-D., Chen J., Luo Y., Guo H., Jiang R.-D., Liu M.-Q., Chen Y., Shen X.-R., Wang X., Zheng X.-S., Zhao K., Chen Q.-J., Deng F., Liu L.-L., Yan B., Zhan F.-X., Wang Y.-Y., Xiao G.-F., Shi Z.-L. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579:270–273. doi: 10.1038/s41586-020-2012-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Geoghegan J.L., Ren X., Storey M., Hadfield J., Jelley L., Jefferies S., Sherwood J., Paine S., Huang S., Douglas J., Mendes F.K., Sporle A., Baker M.G., Murdoch D.R., French N., Simpson C.R., Welch D., Drummond A.J., Holmes E.C., Duchêne S., de Ligt J. Genomic epidemiology reveals transmission patterns and dynamics of SARS-CoV-2 in Aotearoa New Zealand. Nat. Commun. 2020;11:6351. doi: 10.1038/s41467-020-20235-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Tian H., Liu Y., Li Y., Wu C.-H., Chen B., Kraemer M.U.G., Li B., Cai J., Xu B., Yang Q., Wang B., Yang P., Cui Y., Song Y., Zheng P., Wang Q., Bjornstad O.N., Yang R., Grenfell B.T., Pybus O.G., Dye C. An investigation of transmission control measures during the first 50 days of the COVID-19 epidemic in China. Science. 2020;368:638–642. doi: 10.1126/science.abb6105. (80-. ) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Gunadi H., Wibawa Marcellus, Hakim M.S., Daniwijaya E.W., Rizki L.P., Supriyati E., Nugrahaningsih D.A.A., Afiahayati, Siswanto, Iskandar K., Anggorowati N., Kalim A.S., Puspitarani D.A., Athollah K., Arguni E., Nuryastuti T., Wibawa T. Full-length genome characterization and phylogenetic analysis of SARS-CoV-2 virus strains from Yogyakarta and Central Java, Indonesia. Peer J. 2020;8 doi: 10.7717/peerj.10575. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Korber B., Fischer W.M., Gnanakaran S., Yoon H., Theiler J., Abfalterer W., Hengartner N., Giorgi E.E., Bhattacharya T., Foley B., Hastie K.M., Parker M.D., Partridge D.G., Evans C.M., Freeman T.M., de Silva T.I., McDanal C., Perez L.G., Tang H., Moon-Walker A., Whelan S.P., LaBranche C.C., Saphire E.O., Montefiori D.C., Angyal A., Brown R.L., Carrilero L., Green L.R., Groves D.C., Johnson K.J., Keeley A.J., Lindsey B.B., Parsons P.J., Raza M., Rowland-Jones S., Smith N., Tucker R.M., Wang D., Wyles M.D. Tracking changes in SARS-CoV-2 spike: evidence that D614G increases infectivity of the COVID-19 virus. Cell. 2020;182:812–827. doi: 10.1016/j.cell.2020.06.043. e19. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Volz E., Hill V., McCrone J.T., Price A., Jorgensen D., O’Toole Á., Southgate J., Johnson R., Jackson B., Nascimento F.F., Rey S.M., Nicholls S.M., Colquhoun R.M., da Silva Filipe A., Shepherd J., Pascall D.J., Shah R., Jesudason N., Li K., Jarrett R., Pacchiarini N., Bull M., Geidelberg L., Siveroni I., Goodfellow I., Loman N.J., Pybus O.G., Robertson D.L., Thomson E.C., Rambaut A., Connor T.R. Evaluating the effects of SARS-CoV-2 spike mutation D614G on transmissibility and pathogenicity. Cell. 2021;184:64–75. doi: 10.1016/j.cell.2020.11.020. e11. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Plante J.A., Liu Y., Liu J., Xia H., Johnson B.A., Lokugamage K.G., Zhang X., Muruato A.E., Zou J., Fontes-Garfias C.R., Mirchandani D., Scharton D., Bilello J.P., Ku Z., An Z., Kalveram B., Freiberg A.N., Menachery V.D., Xie X., Plante K.S., Weaver S.C., Shi P.-Y. Spike mutation D614G alters SARS-CoV-2 fitness. Nature. 2021;592:116–121. doi: 10.1038/s41586-020-2895-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Zhou B., Thao T.T.N., Hoffmann D., Taddeo A., Ebert N., Labroussaa F., Pohlmann A., King J., Steiner S., Kelly J.N., Portmann J., Halwe N.J., Ulrich L., Trüeb B.S., Fan X., Hoffmann B., Wang L., Thomann L., Lin X., Stalder H., Pozzi B., de Brot S., Jiang N., Cui D., Hossain J., Wilson M.M., Keller M.W., Stark T.J., Barnes J.R., Dijkman R., Jores J., Benarafa C., Wentworth D.E., Thiel V., Beer M. SARS-CoV-2 spike D614G change enhances replication and transmission. Nature. 2021;592:122–127. doi: 10.1038/s41586-021-03361-1. [DOI] [PubMed] [Google Scholar]
  • 10.Yurkovetskiy L., Wang X., Pascal K.E., Tomkins-Tinch C., Nyalile T.P., Wang Y., Baum A., Diehl W.E., Dauphin A., Carbone C., Veinotte K., Egri S.B., Schaffner S.F., Lemieux J.E., Munro J.B., Rafique A., Barve A., Sabeti P.C., Kyratsous C.A., Dudkina N.V., Shen K., Luban J. Structural and functional analysis of the D614G SARS-CoV-2 spike protein variant. Cell. 2020;183:739–751. doi: 10.1016/j.cell.2020.09.032. e8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Isabel S., Graña-Miraglia L., Gutierrez J.M., Bundalovic-Torma C., Groves H.E., Isabel M.R., Eshaghi A., Patel S.N., Gubbay J.B., Poutanen T., Guttman D.S., Poutanen S.M. Evolutionary and structural analyses of SARS-CoV-2 D614G spike protein mutation now documented worldwide. Sci. Rep. 2020;10:14031. doi: 10.1038/s41598-020-70827-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Tong S.Y.C., Giffard P.M. Microbiological applications of high-resolution melting analysis. J. Clin. Microbiol. 2012;50:3418–3421. doi: 10.1128/JCM.01709-12. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Meng Q., Wang X., Wang Y., Dang L., Liu X., Ma X., Chi T., Wang X., Zhao Q., Yang G., Liu M., Huang X., Ma P. Detection of the SARS-CoV-2 D614G mutation using engineered Cas12a guide RNA. Biotechnol. J. 2021;2019:2100040. doi: 10.1002/biot.202100040. [DOI] [PubMed] [Google Scholar]
  • 14.Bustin S., Coward A., Sadler G., Teare L., Nolan T. CoV2-ID, a MIQE-compliant sub-20-min 5-plex RT-PCR assay targeting SARS-CoV-2 for the diagnosis of COVID-19. Sci. Rep. 2020;10:22214. doi: 10.1038/s41598-020-79233-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Zhang Y., Xi H., Juhas M. Biosensing detection of the SARS-CoV-2 D614G mutation. Trends Genet. 2021;37:299–302. doi: 10.1016/j.tig.2020.12.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Niranji S.S., Al-Jaf S.M.A. Comments on “Development of a PCR-RFLP method for detection of D614G mutation in SARS-CoV-2. Infect. Genet. Evol. 2021;87:104661. doi: 10.1016/j.meegid.2020.104661. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Hashemi S.A., Khoshi A., Ghasemzadeh-moghaddam H., Ghafouri M., Taghavi M., Namdar-Ahmadabad H., Azimian A. Development of a PCR-RFLP method for detection of D614G mutation in SARS-CoV-2. Infect. Genet. Evol. 2020;86:104625. doi: 10.1016/j.meegid.2020.104625. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Diaz-Garcia H., Guzmán-Ortiz A.L., Angeles-Floriano T., Parra-Ortega I., López-Martínez B., Martínez-Saucedo M., Aquino-Jarquin G., Sánchez-Urbina R., Quezada H., Granados-Riveron J.T. Genotyping of the major SARS-CoV-2 clade by short-amplicon high-resolution melting (SA-HRM) analysis. Genes. 2021;12:531. doi: 10.3390/genes12040531. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Almomani R., van der Stoep N., Bakker E., den Dunnen J.T., Breuning M.H., Ginjaar I.B. Rapid and cost effective detection of small mutations in the DMD gene by high resolution melting curve analysis. Neuromuscul. Disord. 2009;19:383–390. doi: 10.1016/j.nmd.2009.03.004. [DOI] [PubMed] [Google Scholar]
  • 20.Radvanszky J., Surovy M., Nagyova E., Minarik G., Kadasi L. Comparison of different DNA binding fluorescent dyes for applications of high-resolution melting analysis. Clin. Biochem. 2015;48:609–616. doi: 10.1016/j.clinbiochem.2015.01.010. [DOI] [PubMed] [Google Scholar]
  • 21.Borna T., Salami S.A., Shokrpour M. High resolution melting curve analysis revealed SNPs in major cannabinoid genes associated with drug and non-drug types of cannabis. Biotechnol. Biotechnol. Equip. 2017;31:839–845. [Google Scholar]
  • 22.Riahi A., Kharrat M., Lariani I., Chaabouni-Bouhamed H. High-resolution melting (HRM) assay for the detection of recurrent BRCA1/BRCA2 germline mutations in Tunisian breast/ovarian cancer families. Fam. Cancer. 2014;13:603–609. doi: 10.1007/s10689-014-9740-5. [DOI] [PubMed] [Google Scholar]
  • 23.Miller M., Zorn J., Brielmeier M. High-resolution melting curve analysis for identification of pasteurellaceae species in experimental animal facilities. PloS One. 2015;10 doi: 10.1371/journal.pone.0142560. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Varillas D., Bermejo-Martin J.F., Almansa R., Rojo S., Nogueira B., Eiros J.M., Rico L., Iglesias V., de Lejarazu R.O. A new method for detection of pandemic influenza virus using High Resolution Melting analysis of the neuraminidase gene. J. Virol Methods. 2011;171:284–286. doi: 10.1016/j.jviromet.2010.10.003. [DOI] [PubMed] [Google Scholar]
  • 25.Ababneh M., Ababneh O., Al-Zghoul M.B. High-resolution melting curve analysis for infectious bronchitis virus strain differentiation. Vet. World. 2020;13:400–406. doi: 10.14202/vetworld.2020.400-406. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Liu Y., Markus . 2020. PyHRM [Source Code]https://github.com/liuyigh/PyHRM.git [Google Scholar]
  • 27.Briefs A.M.C.T. PCR – the polymerase chain reaction. Anal. Meth. 2014;6:333–336. doi: 10.1039/c3ay90101g. [DOI] [PubMed] [Google Scholar]
  • 28.Kalthoff D., Beer M., Hoffmann B. High resolution melting analysis: rapid and precise characterisation of recombinant influenza A genomes. Virol. J. 2013;10:1. doi: 10.1186/1743-422X-10-284. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Molina-Mora J.A., Cordero-Laurent E., Godínez A., Calderón-Osorno M., Brenes H., Soto-Garita C., Pérez-Corrales C., Drexler J.F., Moreira-Soto A., Corrales-Aguilar E., Duarte-Martínez F. SARS-CoV-2 genomic surveillance in Costa Rica: evidence of a divergent population and an increased detection of a spike T1117I mutation. Infect. Genet. Evol. 2021;92 doi: 10.1016/j.meegid.2021.104872. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Rambaut A., Holmes E.C., O’Toole Á., Hill V., McCrone J.T., Ruis C., du Plessis L., Pybus O.G. A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology. Nat. Microbiol. 2020;5:1403–1407. doi: 10.1038/s41564-020-0770-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Hoffmann M., Arora P., Groß R., Seidel A., Hörnich B.F., Hahn A.S., Krüger N., Graichen L., Hofmann-Winkler H., Kempf A., Winkler M.S., Schulz S., Jäck H.-M., Jahrsdörfer B., Schrezenmeier H., Müller M., Kleger A., Münch J., Pöhlmann S. SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodies. Cell. 2021;184:2384–2393. doi: 10.1016/j.cell.2021.03.036. e12. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Davies N.G., Jarvis C.I., van Zandvoort K., Clifford S., Sun F.Y., Funk S., Medley G., Jafari Y., Meakin S.R., Lowe R., Quaife M., Waterlow N.R., Eggo R.M., Lei J., Koltai M., Krauer F., Tully D.C., Munday J.D., Showering A., Foss A.M., Prem K., Flasche S., Kucharski A.J., Abbott S., Quilty B.J., Jombart T., Rosello A., Knight G.M., Jit M., Liu Y., Williams J., Hellewell J., O’Reilly K., Chan Y.W.D., Russell T.W., Procter S.R., Endo A., Nightingale E.S., Bosse N.I., Villabona-Arenas C.J., Sandmann F.G., Gimma A., Abbas K., Waites W., Atkins K.E., Barnard R.C., Klepac P., Gibbs H.P., Pearson C.A.B., Brady O., Edmunds W.J., Jewell N.P., Diaz-Ordaz K., Keogh R.H. Increased mortality in community-tested cases of SARS-CoV-2 lineage B.1.1.7. Nature. 2021;593 doi: 10.1038/s41586-021-03426-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Li Y.-D., Chu Z.-Z., Liu X.-G., Jing H.-C., Liu Y.-G., Hao D.-Y. A cost-effective high-resolution melting approach using the EvaGreen dye for DNA polymorphism detection and genotyping in plants. J. Integr. Plant Biol. 2010;52:1036–1042. doi: 10.1111/j.1744-7909.2010.01001.x. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

The data will be published in the GISAID and/or NCBI after the manuscript is published.


Articles from Heliyon are provided here courtesy of Elsevier

RESOURCES